氯沙坦可改善黏多糖贮积症I型的主动脉扩张及心血管疾病。 - Suppr

Suppr

超能文献

Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I.

作者信息

Gonzalez Esteban Alberto, Tavares Angela Maria Vicente, Poletto Edina, Giugliani Roberto, Matte Ursula, Baldo Guilherme

机构信息

Gene Therapy Center, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos, 2350, 90035-903, Porto Alegre, Brazil.

Postgraduate Program in Genetics and Molecular Biology, UFRGS, Porto Alegre, Brazil.

出版信息

J Inherit Metab Dis. 2017 May;40(3):311-312. doi: 10.1007/s10545-017-0014-x. Epub 2017 Feb 3.

DOI:10.1007/s10545-017-0014-x

PMID:28160112

Abstract

摘要

相似文献

Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I.

J Inherit Metab Dis. 2017 May;40(3):311-312. doi: 10.1007/s10545-017-0014-x. Epub 2017 Feb 3.

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.

Eur Heart J. 2013 Dec;34(45):3491-500. doi: 10.1093/eurheartj/eht334. Epub 2013 Sep 2.

The effect of losartan on progressive aortic dilatation in patients with Marfan's syndrome: a meta-analysis of prospective randomized clinical trials.

Int J Cardiol. 2016 Aug 15;217:190-4. doi: 10.1016/j.ijcard.2016.04.186. Epub 2016 May 4.

Aortic Root Dilatation in Mucopolysaccharidosis I-VII.

Int J Mol Sci. 2016 Nov 29;17(12):2004. doi: 10.3390/ijms17122004.

Atherosclerosis, neoatherosclerosis, and vascular disease.

Eur Heart J. 2015 Aug 21;36(32):2121-3. doi: 10.1093/eurheartj/ehv325.

Pravastatin reduces Marfan aortic dilation.

Circulation. 2011 Sep 13;124(11 Suppl):S168-73. doi: 10.1161/CIRCULATIONAHA.110.012187.

Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.

Mayo Clin Proc. 2013 Mar;88(3):271-6. doi: 10.1016/j.mayocp.2012.11.005. Epub 2013 Jan 12.

Marfan Sartan: a randomized, double-blind, placebo-controlled trial.

Eur Heart J. 2015 Aug 21;36(32):2160-6. doi: 10.1093/eurheartj/ehv151. Epub 2015 May 2.

Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome.

Circ Cardiovasc Genet. 2015 Apr;8(2):383-8. doi: 10.1161/CIRCGENETICS.114.000950. Epub 2015 Jan 22.

[Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome].

Rev Esp Cardiol. 2011 Jun;64(6):492-8. doi: 10.1016/j.recesp.2011.02.009. Epub 2011 May 10.

引用本文的文献

Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I.

Mol Genet Metab Rep. 2023 Dec 14;38:101036. doi: 10.1016/j.ymgmr.2023.101036. eCollection 2024 Mar.

Contribution of the innate and adaptive immune systems to aortic dilation in murine mucopolysaccharidosis type I.

Mol Genet Metab. 2022 Mar;135(3):193-205. doi: 10.1016/j.ymgme.2022.01.104. Epub 2022 Feb 3.

Network Analysis Reveals Proteins Associated with Aortic Dilatation in Mucopolysaccharidoses.

Interdiscip Sci. 2021 Mar;13(1):34-43. doi: 10.1007/s12539-020-00406-3. Epub 2021 Jan 21.

Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy.

Diagnostics (Basel). 2020 Dec 23;11(1):16. doi: 10.3390/diagnostics11010016.

Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy.

Heart Vessels. 2019 Feb;34(2):290-295. doi: 10.1007/s00380-018-1242-1. Epub 2018 Aug 22.

本文引用的文献

Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology.

J Inherit Metab Dis. 2017 Mar;40(2):281-289. doi: 10.1007/s10545-016-9988-z. Epub 2016 Oct 14.

Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.

Mol Genet Metab. 2011 Dec;104(4):608-19. doi: 10.1016/j.ymgme.2011.08.018. Epub 2011 Aug 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验